Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › VIR

SUPERSTRING CAPITAL MANAGEMENT LP position in VIR

VIR BIOTECHNOLOGY INC · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 853,685 shares of VIR (VIR BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$8.7M, representing 5.49% of its reported portfolio and ranking #8 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed VIR holdings in 3 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)853.68K sh
Reported value held$8.70M
Portfolio Weight5.49%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's VIR position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in VIR in Q3 2025 at 150,312 shares (US$858K). The position peaked in Q2 2026 at 853,685 shares, worth US$8.7M. Across 3 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 853,685 shares valued at US$8.7M — an increase of 123,137 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 150.31K $858.28K New
Q1 2026 730.55K $6.55M New
Q2 2026 853.68K $8.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VIR and 13F data

VIR (VIR BIOTECHNOLOGY INC) is a Health Care company. 49 other funds we track also report a position in VIR — the largest reported positions include ARCH Venture Management, LLC (US$129.4M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$87.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VIR

All VIR fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held VIR?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed VIR holdings in 3 of the last 4 reported quarters, going back to Q3 2025.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in VIR?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 853.68K shares of VIR (VIR BIOTECHNOLOGY INC), valued at $8.70M, representing 5.49% of its reported portfolio and ranking #8.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling VIR?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in VIR. The position peaked in Q2 2026 at 853.68K shares.

Which other funds hold VIR?

Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.